*Result*: Benefit of treatment individualization in patients with chronic hepatitis C receiving peginterferon alfa-2a and ribavirin in a large noninterventional cohort study
*Title*:
Benefit of treatment individualization in patients with chronic hepatitis C receiving peginterferon alfa-2a and ribavirin in a large noninterventional cohort study / Wolf Peter Hofmann, Stefan Mauss, Thomas Lutz, Andreas Schober, Klaus Böker, Gero Moog, Axel Baumgarten, Heike Pfeiffer-Vornkahl, Ulrich Alshuth, Dietrich Hüppe, Heiner Wedemeyer, Michael P. Manns, Eckart Schott
*Author/editor-in-chief*:
Hofmann, Wolf-Peter (Verfasser) ; Mauss, Stefan (Verfasser) ; Lutz, Thomas (Verfasser); Schober, Andreas (Verfasser) ; Böker, Klaus H. W. (Verfasser) ; Moog, Gero (Verfasser); Baumgarten, Axel (Verfasser); Pfeiffer-Vornkahl, Heike (Verfasser); Alshuth, Ulrich (Verfasser); Hüppe, Dietrich (Verfasser); Wedemeyer, Heiner (Verfasser) ; Manns, Michael P. (Verfasser) ; Schott, Eckart (Verfasser)
*Published in*:
PLOS ONE. - San Francisco, California, US : PLOS, 2006-. - Online-Ressource. - ISSN 1932-6203. - Band 10, Heft 7 (2015)
*show_all_articles*
*show_all_articles*
*Distribution*:
[Frankfurt am Main] : [Universitätsbibliothek Johann Christian Senckenberg]
*Physical description scale*:
1 Online-Ressource (16 Seiten)
*Format*:
*Language*:
*eng*
*DOI*:
10.1371/journal.pone.0134839